TABLE 3.
Patient laboratory characteristics
| COVID‐19 negative (n = 26) | COVID‐19 positive (n = 34) | P‐value | |
|---|---|---|---|
| Leukocytes (103) | 10.2 ± 2.7 | 9.3 ± 3.5 | .26 |
| Neutrophils (%) | 74.4 ± 12.9 | 78.3 ± 10.6 | .20 |
| Lymphocytes (%) | 11.3 ± 5.7 | 14.2 ± 6.9 | .08 |
| Haemoglobin (g/dL) | 12.6 ± 2.2 | 12.9 ± 2.1 | .61 |
| Haematocrit (%) | 40.1 ± 7.8 | 41.2 ± 7.9 | .60 |
| Platelets (103) | 272 ± 110 | 231 ± 98 | .14 |
| Prothrombin time (s) | 12.2 ± 0.9 | 13.5 ± 2.3 | .012 |
| Activated partial thromboplastin time (s) | 30.7 ± 5.7 | 28.5 ± 3.8 | .07 |
| Glucose (mmol/L) | 7.1 ± 2.9 | 5.8 ± 1.6 | .039 |
| Creatinine (µmol/L) | 101.5 ± 36.4 | 98.8 ± 46.9 | .81 |
| Aspartate transaminase (IU/L) | 43.8 ± 16.7 | 51.3 ± 22.9 | .16 |
| Alanine transaminase (IU/L) | 54.4 ± 31.3 | 45.1 ± 21.9 | .18 |
| Na (mEq/L) | 141.1 ± 2.7 | 139.5 ± 3.5 | .21 |
| K (mEq/L) | 4.0 ± 0.5 | 3.8 ± 0.6 | .31 |
| Cl (mEq/L) | 105.9 ± 5.8 | 99.3 ± 24.1 | .35 |
| Ca (mEq/L) | 4.2 ± 0.2 | 4.0 ± 0.2 | .76 |
| Mg (mEq/L) | 1.7 ± 0.4 | 1.8 ± 0.3 | .54 |
| PO4 (mEq/L) | 1.4 ± 0.3 | 1.3 ± 0.2 | .55 |
| High‐sensitivity CRP (mg/L) | 6.6 ± 3.1 | 8.9 ± 0.8 | <.001 |